Industry: Medical Devices & Consumables
Published Date: 2024-04-12
Pages: 109 Pages
Report ld: 2922989
Request Sample
Customized Report
Female Urinary Incontinence Treatment Device Market Size(US$)

CAGR 2024-2030
7%
Market Size,2030
USD 1,500.7
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
Female urinary incontinence is diagnosed as a condition which causes unintentional urination. Urinary incontinence or stress urinary incontinence usually occurs during physical activities such as running, sneezing, coughing, or even during lifting weights as these activities exert pressures on the urinary bladder. Urinary urge and stress incontinence are different from each other, as the former is caused when the bladder muscles are contracted. Stress urinary incontinence affects women more than men and is mostly caused due to weak sphincter muscle, which can lead to social isolation. Female urinary incontinence is of two types: first is urethral hypermobility and secondly due to intrinsic sphincter deficiency. In the case of urethra hypermobility, increasing abdominal pressure changes the position of urethra. On the other hand in intrinsic sphincter the deficiency, the sphincter has lost its ability to seal in intrinsic sphincter deficiency. Women above 60 year of age often suffer from female stress urinary incontinence due to the weakening of their pelvic muscles. Female stress urinary incontinence can also occur during pregnancy, hysterectomy, menopause, chronic disorders such as tuberculosis, congenital diseases, obesity, and anatomical predisposition.
The global Female Urinary Incontinence Treatment Device market is projected to grow from US$ 1000 million in 2024 to US$ 1500.7 million by 2030, at a Compound Annual Growth Rate (CAGR) of 7.0% during the forecast period.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Covers:
This report presents an overview of global market for Female Urinary Incontinence Treatment Device, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Female Urinary Incontinence Treatment Device, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Female Urinary Incontinence Treatment Device, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Female Urinary Incontinence Treatment Device sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Female Urinary Incontinence Treatment Device market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Female Urinary Incontinence Treatment Device sales, projected growth trends, production technology, application and end-user industry.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Female Urinary Incontinence Treatment Device in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Female Urinary Incontinence Treatment Device manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Female Urinary Incontinence Treatment Device sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Female Urinary Incontinence Treatment Device Product Introduction
1.2 Market by Type
1.2.1 Global Female Urinary Incontinence Treatment Device Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Urethral Devices
1.2.3 Internal Vaginal Devices
1.3 Market by Application
1.3.1 Global Female Urinary Incontinence Treatment Device Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Female Urinary Incontinence Treatment Device Sales Estimates and Forecasts 2019-2030
2.2 Global Female Urinary Incontinence Treatment Device Revenue by Region
2.2.1 Global Female Urinary Incontinence Treatment Device Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Female Urinary Incontinence Treatment Device Revenue by Region (2019-2024)
2.2.3 Global Female Urinary Incontinence Treatment Device Revenue by Region (2025-2030)
2.2.4 Global Female Urinary Incontinence Treatment Device Revenue Market Share by Region (2019-2030)
2.3 Global Female Urinary Incontinence Treatment Device Sales Estimates and Forecasts 2019-2030
2.4 Global Female Urinary Incontinence Treatment Device Sales by Region
2.4.1 Global Female Urinary Incontinence Treatment Device Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Female Urinary Incontinence Treatment Device Sales by Region (2019-2024)
2.4.3 Global Female Urinary Incontinence Treatment Device Sales by Region (2025-2030)
2.4.4 Global Female Urinary Incontinence Treatment Device Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Female Urinary Incontinence Treatment Device Sales by Manufacturers
3.1.1 Global Female Urinary Incontinence Treatment Device Sales by Manufacturers (2019-2024)
3.1.2 Global Female Urinary Incontinence Treatment Device Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Female Urinary Incontinence Treatment Device in 2023
3.2 Global Female Urinary Incontinence Treatment Device Revenue by Manufacturers
3.2.1 Global Female Urinary Incontinence Treatment Device Revenue by Manufacturers (2019-2024)
3.2.2 Global Female Urinary Incontinence Treatment Device Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Female Urinary Incontinence Treatment Device Revenue in 2023
3.3 Global Key Players of Female Urinary Incontinence Treatment Device, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Female Urinary Incontinence Treatment Device Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Female Urinary Incontinence Treatment Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Female Urinary Incontinence Treatment Device, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Female Urinary Incontinence Treatment Device, Product Offered and Application
3.8 Global Key Manufacturers of Female Urinary Incontinence Treatment Device, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Female Urinary Incontinence Treatment Device Sales by Type
4.1.1 Global Female Urinary Incontinence Treatment Device Historical Sales by Type (2019-2024)
4.1.2 Global Female Urinary Incontinence Treatment Device Forecasted Sales by Type (2025-2030)
4.1.3 Global Female Urinary Incontinence Treatment Device Sales Market Share by Type (2019-2030)
4.2 Global Female Urinary Incontinence Treatment Device Revenue by Type
4.2.1 Global Female Urinary Incontinence Treatment Device Historical Revenue by Type (2019-2024)
4.2.2 Global Female Urinary Incontinence Treatment Device Forecasted Revenue by Type (2025-2030)
4.2.3 Global Female Urinary Incontinence Treatment Device Revenue Market Share by Type (2019-2030)
4.3 Global Female Urinary Incontinence Treatment Device Price by Type
4.3.1 Global Female Urinary Incontinence Treatment Device Price by Type (2019-2024)
4.3.2 Global Female Urinary Incontinence Treatment Device Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Female Urinary Incontinence Treatment Device Sales by Application
5.1.1 Global Female Urinary Incontinence Treatment Device Historical Sales by Application (2019-2024)
5.1.2 Global Female Urinary Incontinence Treatment Device Forecasted Sales by Application (2025-2030)
5.1.3 Global Female Urinary Incontinence Treatment Device Sales Market Share by Application (2019-2030)
5.2 Global Female Urinary Incontinence Treatment Device Revenue by Application
5.2.1 Global Female Urinary Incontinence Treatment Device Historical Revenue by Application (2019-2024)
5.2.2 Global Female Urinary Incontinence Treatment Device Forecasted Revenue by Application (2025-2030)
5.2.3 Global Female Urinary Incontinence Treatment Device Revenue Market Share by Application (2019-2030)
5.3 Global Female Urinary Incontinence Treatment Device Price by Application
5.3.1 Global Female Urinary Incontinence Treatment Device Price by Application (2019-2024)
5.3.2 Global Female Urinary Incontinence Treatment Device Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Female Urinary Incontinence Treatment Device Market Size by Type
6.1.1 US & Canada Female Urinary Incontinence Treatment Device Sales by Type (2019-2030)
6.1.2 US & Canada Female Urinary Incontinence Treatment Device Revenue by Type (2019-2030)
6.2 US & Canada Female Urinary Incontinence Treatment Device Market Size by Application
6.2.1 US & Canada Female Urinary Incontinence Treatment Device Sales by Application (2019-2030)
6.2.2 US & Canada Female Urinary Incontinence Treatment Device Revenue by Application (2019-2030)
6.3 US & Canada Female Urinary Incontinence Treatment Device Market Size by Country
6.3.1 US & Canada Female Urinary Incontinence Treatment Device Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Female Urinary Incontinence Treatment Device Sales by Country (2019-2030)
6.3.3 US & Canada Female Urinary Incontinence Treatment Device Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Female Urinary Incontinence Treatment Device Market Size by Type
7.1.1 Europe Female Urinary Incontinence Treatment Device Sales by Type (2019-2030)
7.1.2 Europe Female Urinary Incontinence Treatment Device Revenue by Type (2019-2030)
7.2 Europe Female Urinary Incontinence Treatment Device Market Size by Application
7.2.1 Europe Female Urinary Incontinence Treatment Device Sales by Application (2019-2030)
7.2.2 Europe Female Urinary Incontinence Treatment Device Revenue by Application (2019-2030)
7.3 Europe Female Urinary Incontinence Treatment Device Market Size by Country
7.3.1 Europe Female Urinary Incontinence Treatment Device Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Female Urinary Incontinence Treatment Device Sales by Country (2019-2030)
7.3.3 Europe Female Urinary Incontinence Treatment Device Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Female Urinary Incontinence Treatment Device Market Size
8.1.1 China Female Urinary Incontinence Treatment Device Sales (2019-2030)
8.1.2 China Female Urinary Incontinence Treatment Device Revenue (2019-2030)
8.2 China Female Urinary Incontinence Treatment Device Market Size by Application
8.2.1 China Female Urinary Incontinence Treatment Device Sales by Application (2019-2030)
8.2.2 China Female Urinary Incontinence Treatment Device Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Female Urinary Incontinence Treatment Device Market Size by Type
9.1.1 Asia Female Urinary Incontinence Treatment Device Sales by Type (2019-2030)
9.1.2 Asia Female Urinary Incontinence Treatment Device Revenue by Type (2019-2030)
9.2 Asia Female Urinary Incontinence Treatment Device Market Size by Application
9.2.1 Asia Female Urinary Incontinence Treatment Device Sales by Application (2019-2030)
9.2.2 Asia Female Urinary Incontinence Treatment Device Revenue by Application (2019-2030)
9.3 Asia Female Urinary Incontinence Treatment Device Sales by Region
9.3.1 Asia Female Urinary Incontinence Treatment Device Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Female Urinary Incontinence Treatment Device Revenue by Region (2019-2030)
9.3.3 Asia Female Urinary Incontinence Treatment Device Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Female Urinary Incontinence Treatment Device Market Size by Type
10.1.1 Middle East, Africa and Latin America Female Urinary Incontinence Treatment Device Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Female Urinary Incontinence Treatment Device Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Female Urinary Incontinence Treatment Device Market Size by Application
10.2.1 Middle East, Africa and Latin America Female Urinary Incontinence Treatment Device Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Female Urinary Incontinence Treatment Device Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Female Urinary Incontinence Treatment Device Sales by Country
10.3.1 Middle East, Africa and Latin America Female Urinary Incontinence Treatment Device Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Female Urinary Incontinence Treatment Device Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Female Urinary Incontinence Treatment Device Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 BD
11.1.1 BD Company Information
11.1.2 BD Overview
11.1.3 BD Female Urinary Incontinence Treatment Device Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 BD Female Urinary Incontinence Treatment Device Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 BD Recent Developments
11.2 Karl Storz
11.2.1 Karl Storz Company Information
11.2.2 Karl Storz Overview
11.2.3 Karl Storz Female Urinary Incontinence Treatment Device Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Karl Storz Female Urinary Incontinence Treatment Device Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Karl Storz Recent Developments
11.3 Johnson and Johnson
11.3.1 Johnson and Johnson Company Information
11.3.2 Johnson and Johnson Overview
11.3.3 Johnson and Johnson Female Urinary Incontinence Treatment Device Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Johnson and Johnson Female Urinary Incontinence Treatment Device Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Johnson and Johnson Recent Developments
11.4 Coloplast
11.4.1 Coloplast Company Information
11.4.2 Coloplast Overview
11.4.3 Coloplast Female Urinary Incontinence Treatment Device Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Coloplast Female Urinary Incontinence Treatment Device Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Coloplast Recent Developments
11.5 Boston Scientific
11.5.1 Boston Scientific Company Information
11.5.2 Boston Scientific Overview
11.5.3 Boston Scientific Female Urinary Incontinence Treatment Device Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Boston Scientific Female Urinary Incontinence Treatment Device Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Boston Scientific Recent Developments
11.6 Teleflex
11.6.1 Teleflex Company Information
11.6.2 Teleflex Overview
11.6.3 Teleflex Female Urinary Incontinence Treatment Device Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Teleflex Female Urinary Incontinence Treatment Device Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Teleflex Recent Developments
11.7 Medtronic
11.7.1 Medtronic Company Information
11.7.2 Medtronic Overview
11.7.3 Medtronic Female Urinary Incontinence Treatment Device Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Medtronic Female Urinary Incontinence Treatment Device Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Medtronic Recent Developments
11.8 InControl Medical
11.8.1 InControl Medical Company Information
11.8.2 InControl Medical Overview
11.8.3 InControl Medical Female Urinary Incontinence Treatment Device Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 InControl Medical Female Urinary Incontinence Treatment Device Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 InControl Medical Recent Developments
11.9 Atlantic Therapeutics Group
11.9.1 Atlantic Therapeutics Group Company Information
11.9.2 Atlantic Therapeutics Group Overview
11.9.3 Atlantic Therapeutics Group Female Urinary Incontinence Treatment Device Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Atlantic Therapeutics Group Female Urinary Incontinence Treatment Device Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Atlantic Therapeutics Group Recent Developments
11.10 Axonics Modulation Technologies
11.10.1 Axonics Modulation Technologies Company Information
11.10.2 Axonics Modulation Technologies Overview
11.10.3 Axonics Modulation Technologies Female Urinary Incontinence Treatment Device Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Axonics Modulation Technologies Female Urinary Incontinence Treatment Device Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Axonics Modulation Technologies Recent Developments
11.11 Laborie
11.11.1 Laborie Company Information
11.11.2 Laborie Overview
11.11.3 Laborie Female Urinary Incontinence Treatment Device Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 Laborie Female Urinary Incontinence Treatment Device Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Laborie Recent Developments
11.12 Micron Medical
11.12.1 Micron Medical Company Information
11.12.2 Micron Medical Overview
11.12.3 Micron Medical Female Urinary Incontinence Treatment Device Sales, Price, Revenue and Gross Margin (2019-2024)
11.12.4 Micron Medical Female Urinary Incontinence Treatment Device Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Micron Medical Recent Developments
11.13 American Medical Solutions
11.13.1 American Medical Solutions Company Information
11.13.2 American Medical Solutions Overview
11.13.3 American Medical Solutions Female Urinary Incontinence Treatment Device Sales, Price, Revenue and Gross Margin (2019-2024)
11.13.4 American Medical Solutions Female Urinary Incontinence Treatment Device Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 American Medical Solutions Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Female Urinary Incontinence Treatment Device Industry Chain Analysis
12.2 Female Urinary Incontinence Treatment Device Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Female Urinary Incontinence Treatment Device Production Mode & Process
12.4 Female Urinary Incontinence Treatment Device Sales and Marketing
12.4.1 Female Urinary Incontinence Treatment Device Sales Channels
12.4.2 Female Urinary Incontinence Treatment Device Distributors
12.5 Female Urinary Incontinence Treatment Device Customers
13 Market Dynamics
13.1 Female Urinary Incontinence Treatment Device Industry Trends
13.2 Female Urinary Incontinence Treatment Device Market Drivers
13.3 Female Urinary Incontinence Treatment Device Market Challenges
13.4 Female Urinary Incontinence Treatment Device Market Restraints
14 Key Findings in The Global Female Urinary Incontinence Treatment Device Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Female Urinary Incontinence Treatment Device was estimated to be worth US$ 1130 million in 2025 and is projected to reach US$ 1803 million, growing at a CAGR of 7.0% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 143
USD 3950.00
(Single User License)
The global Female Urinary Incontinence Treatment Device market was valued at US$ 1130 million in 2025 and is anticipated to reach US$ 1803 million by 2032, at a CAGR of 7.0% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 122
USD 2900.00
(Single User License)
The global Female Urinary Incontinence Treatment Device market size was US$ 1063 million in 2024 and is forecast to a readjusted size of US$ 1696 million by 2031 with a CAGR of 7.0% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 96
USD 4250.00
(Single User License)
The global Female Urinary Incontinence Treatment Device market is projected to grow from US$ 1063 million in 2024 to US$ 1696 million by 2031, at a CAGR of 7.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 162
USD 4900.00
(Single User License)
The global market for Female Urinary Incontinence Treatment Device was valued at US$ 1063 million in the year 2024 and is projected to reach a revised size of US$ 1696 million by 2031, growing at a CAGR of 7.0% during the forecast period.
Published Date: 2025-01-16
Pages: 94
USD 2900.00
(Single User License)
The global market for Female Urinary Incontinence Treatment Device was estimated to be worth US$ 1063 million in 2024 and is forecast to a readjusted size of US$ 1696 million by 2031 with a CAGR of 7.0% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 126
USD 3950.00
(Single User License)
Female urinary incontinence is diagnosed as a condition which causes unintentional urination. Urinary incontinence or stress urinary incontinence usually occurs during physical activities such as running, sneezing, coughing, or even during lifting weights as these activities exert pressures on the urinary bladder. Urinary urge and stress incontinence are different from each other, as the former is caused when the bladder muscles are contracted. Stress urinary incontinence affects women more than men and is mostly caused due to weak sphincter muscle, which can lead to social isolation. Female urinary incontinence is of two types: first is urethral hypermobility and secondly due to intrinsic sphincter deficiency. In the case of urethra hypermobility, increasing abdominal pressure changes the position of urethra. On the other hand in intrinsic sphincter the deficiency, the sphincter has lost its ability to seal in intrinsic sphincter deficiency. Women above 60 year of age often suffer from female stress urinary incontinence due to the weakening of their pelvic muscles. Female stress urinary incontinence can also occur during pregnancy, hysterectomy, menopause, chronic disorders such as tuberculosis, congenital diseases, obesity, and anatomical predisposition.
Published Date: 2024-01-17
Pages: 91
USD 2900.00
(Single User License)
Female urinary incontinence is diagnosed as a condition which causes unintentional urination. Urinary incontinence or stress urinary incontinence usually occurs during physical activities such as running, sneezing, coughing, or even during lifting weights as these activities exert pressures on the urinary bladder. Urinary urge and stress incontinence are different from each other, as the former is caused when the bladder muscles are contracted. Stress urinary incontinence affects women more than men and is mostly caused due to weak sphincter muscle, which can lead to social isolation. Female urinary incontinence is of two types: first is urethral hypermobility and secondly due to intrinsic sphincter deficiency. In the case of urethra hypermobility, increasing abdominal pressure changes the position of urethra. On the other hand in intrinsic sphincter the deficiency, the sphincter has lost its ability to seal in intrinsic sphincter deficiency. Women above 60 year of age often suffer from female stress urinary incontinence due to the weakening of their pelvic muscles. Female stress urinary incontinence can also occur during pregnancy, hysterectomy, menopause, chronic disorders such as tuberculosis, congenital diseases, obesity, and anatomical predisposition.
Published Date: 2024-01-10
Pages: 116
USD 3950.00
(Single User License)
The global market for Female Urinary Incontinence Treatment Device was estimated to be worth US$ 1130 million in 2025 and is projected to reach US$ 1803 million, growing at a CAGR of 7.0% from 2026 to 2032.
Published: 2026-06-16
Pages: 143
The global Female Urinary Incontinence Treatment Device market was valued at US$ 1130 million in 2025 and is anticipated to reach US$ 1803 million by 2032, at a CAGR of 7.0% from 2026 to 2032.
Published: 2026-04-17
Pages: 122
The global Female Urinary Incontinence Treatment Device market size was US$ 1063 million in 2024 and is forecast to a readjusted size of US$ 1696 million by 2031 with a CAGR of 7.0% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 96
The global Female Urinary Incontinence Treatment Device market is projected to grow from US$ 1063 million in 2024 to US$ 1696 million by 2031, at a CAGR of 7.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 162
The global market for Female Urinary Incontinence Treatment Device was valued at US$ 1063 million in the year 2024 and is projected to reach a revised size of US$ 1696 million by 2031, growing at a CAGR of 7.0% during the forecast period.
Published: 2025-01-16
Pages: 94
The global market for Female Urinary Incontinence Treatment Device was estimated to be worth US$ 1063 million in 2024 and is forecast to a readjusted size of US$ 1696 million by 2031 with a CAGR of 7.0% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 126
Female urinary incontinence is diagnosed as a condition which causes unintentional urination. Urinary incontinence or stress urinary incontinence usually occurs during physical activities such as running, sneezing, coughing, or even during lifting weights as these activities exert pressures on the urinary bladder. Urinary urge and stress incontinence are different from each other, as the former is caused when the bladder muscles are contracted. Stress urinary incontinence affects women more than men and is mostly caused due to weak sphincter muscle, which can lead to social isolation. Female urinary incontinence is of two types: first is urethral hypermobility and secondly due to intrinsic sphincter deficiency. In the case of urethra hypermobility, increasing abdominal pressure changes the position of urethra. On the other hand in intrinsic sphincter the deficiency, the sphincter has lost its ability to seal in intrinsic sphincter deficiency. Women above 60 year of age often suffer from female stress urinary incontinence due to the weakening of their pelvic muscles. Female stress urinary incontinence can also occur during pregnancy, hysterectomy, menopause, chronic disorders such as tuberculosis, congenital diseases, obesity, and anatomical predisposition.
Published: 2024-01-17
Pages: 91
Female urinary incontinence is diagnosed as a condition which causes unintentional urination. Urinary incontinence or stress urinary incontinence usually occurs during physical activities such as running, sneezing, coughing, or even during lifting weights as these activities exert pressures on the urinary bladder. Urinary urge and stress incontinence are different from each other, as the former is caused when the bladder muscles are contracted. Stress urinary incontinence affects women more than men and is mostly caused due to weak sphincter muscle, which can lead to social isolation. Female urinary incontinence is of two types: first is urethral hypermobility and secondly due to intrinsic sphincter deficiency. In the case of urethra hypermobility, increasing abdominal pressure changes the position of urethra. On the other hand in intrinsic sphincter the deficiency, the sphincter has lost its ability to seal in intrinsic sphincter deficiency. Women above 60 year of age often suffer from female stress urinary incontinence due to the weakening of their pelvic muscles. Female stress urinary incontinence can also occur during pregnancy, hysterectomy, menopause, chronic disorders such as tuberculosis, congenital diseases, obesity, and anatomical predisposition.
Published: 2024-01-10
Pages: 116
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now